Obesity medicine is a medical specialty focused on diagnosing, treating, and preventing obesity as a chronic disease. Rather than simply advising patients to “eat less and move more,” physicians in this field use a combination of nutrition therapy, physical activity planning, behavioral strategies, and medications to address the biological, psychological, and environmental factors that drive weight gain. The American Medical Association formally recognized obesity as a disease in 2013, and the specialty has grown rapidly since, with over 10,700 physicians earning board certification through the American Board of Obesity Medicine (ABOM) between 2012 and 2024.
Why Obesity Is Treated as a Disease
For decades, excess weight was framed primarily as a lifestyle problem. That changed when major medical organizations began recognizing obesity as a chronic, systemic disease with distinct biological mechanisms. The body regulates weight through a complex network of hormones, brain signaling, and metabolic processes that can become disrupted. When that happens, the body actively defends a higher weight set point, making sustained weight loss through willpower alone extremely difficult for many people.
This shift in understanding is what separates obesity medicine from general weight-loss advice. Specialists in this field treat obesity the way cardiologists treat heart disease or endocrinologists treat diabetes: as a condition with identifiable causes, measurable markers, and evidence-based treatments. The AMA’s recognition described obesity as having “multiple pathophysiological aspects requiring a range of interventions.”
The Four Pillars of Treatment
The Obesity Medicine Association organizes treatment around four pillars: nutrition therapy, physical activity, behavioral modification, and medical interventions. These aren’t offered as a generic checklist. An obesity medicine specialist tailors the combination based on your health history, metabolic profile, and personal circumstances.
Nutrition therapy goes beyond calorie counting. Specialists build eating plans around your existing food knowledge, cooking skills, cultural preferences, and lifestyle. The goal is a sustainable caloric balance rather than a temporary diet.
Physical activity is prescribed with individual limitations in mind. Cardio and strength training both play a role, not just for burning calories but for building lean muscle mass, which raises your resting metabolism and improves heart and metabolic health over time.
Behavioral modification addresses the habits, emotions, and psychological patterns that contribute to weight gain. This can include cognitive-behavioral therapy, mindfulness techniques, and structured goal setting to help you identify and replace detrimental eating patterns.
Medical interventions include FDA-approved medications and, when appropriate, referrals for bariatric surgery. Medications aren’t treated as shortcuts but as tools that work alongside the other three pillars, particularly for patients whose biology makes lifestyle changes alone insufficient.
What Happens at a First Appointment
An initial visit with an obesity medicine specialist is far more comprehensive than stepping on a scale. The evaluation covers eight domains: your weight history over time, nutritional habits, eating behaviors (including patterns like emotional eating or binge eating), physical activity level, sleep quality, current medications and supplements, mental health, and social factors like food access, financial constraints, and family dynamics.
Diagnosis increasingly moves beyond BMI alone. Newer clinical frameworks evaluate waist circumference, waist-to-hip ratio, and waist-to-height ratio alongside metabolic markers like blood sugar, cholesterol levels, kidney function, and cardiovascular risk scores. These measurements help determine whether excess body fat is actively causing organ dysfunction or raising the risk of complications. The goal is to establish a baseline, identify specific treatment targets, and build a personalized care plan with patient-centered goals rather than arbitrary weight targets.
How Modern Medications Work
The newest generation of obesity medications has transformed the field. Six drugs are currently approved by the FDA for long-term weight management in adults: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide (Wegovy), and tirzepatide (Zepbound). A seventh, setmelanotide, is approved for rare genetic forms of obesity.
The most effective options belong to a class that mimics gut hormones your body naturally produces after eating. These medications activate receptors in the brain that regulate appetite, helping you feel full sooner and reducing food cravings. They also improve how your body handles blood sugar by stimulating insulin release, reducing the liver’s sugar production, and increasing insulin sensitivity in your tissues.
The clinical results reflect a major leap forward. Older FDA-approved obesity medications produced average weight reductions of roughly 3 to 9 percent beyond what patients achieved with placebo. Semaglutide raised that to about 12.4 percent. Tirzepatide, which activates two hormone receptors instead of one, produced average weight loss of 15 to 21 percent of body weight in a major trial published in the New England Journal of Medicine. For context, bariatric surgery typically results in 25 to 30 percent weight loss at one to two years.
Who Practices Obesity Medicine
Obesity medicine specialists come from a range of backgrounds. Physicians from internal medicine, family medicine, endocrinology, pediatrics, and other fields can pursue ABOM certification by demonstrating specialized knowledge in obesity care. The specialty is growing fast and skewing younger. Between 2017 and 2024, nearly 8,640 physicians earned initial ABOM certification, more than four times the number certified in the previous five-year period. Almost half of newly certified physicians were under 40, and nearly two-thirds were women.
Certification signals that a physician has specific training in the complex biology of weight regulation, the evaluation of obesity-related complications across multiple organ systems, and evidence-based treatment options. This matters because general practitioners typically receive limited obesity training in medical school and residency.
Insurance Coverage Is Shifting
One of the biggest barriers to obesity medicine has been cost. Many insurers historically excluded weight-loss treatments, and Medicare specifically prohibited Part D coverage of medications “when used for weight loss.” That’s beginning to change. In late 2024, the Centers for Medicare and Medicaid Services proposed reinterpreting that exclusion to allow Part D coverage of anti-obesity medications for beneficiaries with obesity.
If finalized, the policy change would expand coverage to an estimated 3.4 million Medicare enrollees who have obesity but don’t currently qualify for coverage through another diagnosis like type 2 diabetes. It would also ripple into Medicaid, where states covering prescription drugs would be required to cover these medications for enrollees with obesity, potentially reaching around 4 million additional adults. The projected federal cost is significant: $24.8 billion for Medicare and $14.8 billion for Medicaid over ten years. But proponents argue these costs would be offset by reductions in obesity-related conditions like heart disease, diabetes, and joint replacements.
Private insurance coverage varies widely. Some employer plans and commercial insurers now cover obesity medications and specialist visits, while others still classify them as elective. Checking your specific plan’s formulary and prior authorization requirements before starting treatment can save considerable frustration.